CYP cynata therapeutics limited

Ann: Capital Raising Presentation, page-69

  1. 2,282 Posts.
    lightbulb Created with Sketch. 1205
    On page 5 of the presentation pdf, under the heading Why Mesenchymal Stem Cells (MSCs)? is a reference to 2 Kelly K and Rasko J. Frontiers in Immunology. 12 October 2021.

    I've just come from checking the Frontiers in Immunology website for the second time - here is the link

    https://www.frontiersin.org/journals/immunology/volumes?volume-id=735


    I could not find the paper in the time zone 12 October 2021 or by searching on Kelly or Rasko and the paper's title isn't included in the reference.

    I did see 23 other papers on 12 October 2021 but a match for the reference on the presentation was not there - unless I missed it twice now.

    Could someone please confirm ?

    I am familiar with the other referenced paper - Aggarwal et al 2005 - its quite some time ago - and a favored reference by Mesoblast in ODAC submissions and patent processing updates etc? 2005 is really quite some time ago. A lot has changed in terms of the technology that can be brought to bare to profile cells - so I'd like to see what work Kelly and Rasko actually have done more recently. The other immunology articles around and since 2021 suggest the work is considerable.



    Last edited by JB1975: 17/04/23
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
17.0¢
Change
0.015(9.68%)
Mkt cap ! $38.41M
Open High Low Value Volume
15.5¢ 17.0¢ 15.5¢ $47.10K 289.1K

Buyers (Bids)

No. Vol. Price($)
1 50000 16.5¢
 

Sellers (Offers)

Price($) Vol. No.
17.0¢ 23813 3
View Market Depth
Last trade - 16.10pm 27/06/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.